Monoclonal Gammopathy of Undetermined Significance (MGUS) Information Sheet
Search for mgus returned 7 results
Myeloma shares some similar features and symptoms with other blood disorders, including:
Waldenström macroglobulinemia (WM)
Heavy chain disease
Light chain deposition disease (LCDD)
Plasma cell leukemia (PCL)
Monoclonal Gammopathy This condition, also called “benign monoclonal gammopathy,” “monoclonal gammopathy of unknown or undetermined significance” (MGUS) and other names, ...
Connecting African American Communities to
Information, Expert Care, and Support As black Americans are at twice the risk for myeloma as whites, The Leukemia & Lymphoma Society has created Myeloma Link to increase access to education and treatment for myeloma in African American communities. LEARN MORE Myeloma Is a type of cancer that begins in the bone marrow. It is a cancer of plasma cells, which are a type of white blood cell ...
Myeloma Is a type of cancer that begins in the bone marrow. It affects the plasma cells. Belongs to a spectrum of disorders referred to as "plasma cell dyscrasia." Has several forms: Multiple myeloma is most common: More than 90 percent of people with myeloma have this type. Multiple myeloma affects several different areas of the body. Plasmacytoma - only one site of myeloma cells evident in the body, such as in the bone, skin, muscle, or lung. ...Read more
Identify and develop safer, more effective treatment paradigms for patients with hematological malignancies.
LLS has formed a partnership with Celgene to create the first of such RFPs that will build the foundation of this new LLS initiative. This initiative will identify and fund priority research areas, with support from biotech and pharmaceutical partners in order to address significant unmet medical needs. The near-term goal of this program is to advance the scientific and medica ...
LLS Specialized Center of Research Program Surpasses $285 Million Mark
White Plains, NY (October 15, 2013) - The Leukemia & Lymphoma Society (LLS) today announced it has awarded four new grants through its prestigious Marshall A. Lichtman Specialized Center of Research (SCOR) research initiative, bringing the program's total funding to $285 million since its inception in 2000. The innovative SCOR program funds teams of researchers representing different disciplines and e ...